{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:44:24Z","timestamp":1793137464961,"version":"4.5.0"},"reference-count":89,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes. However, people with T1D were largely excluded from these CKD therapeutic development programmes. Recent treatment advancements for people with T2D include the introduction of sodium\u2013glucose cotransporter 2 inhibitors, a nonsteroidal mineralocorticoid antagonist, and glucagon\u2010like peptide\u20101 receptor agonists. The development and progression of CKD in people with T1D are driven by a constellation of risk factors such as hyperglycemia, hypertension, obesity, and others that share common mechanistic links with T2D. As such, a compelling rationale exists for focused studies of these therapeutic classes for the treatment of CKD in T1D. Additionally, care provided by a coordinated team of primary care clinicians, endocrinologists, nephrologists, and cardiologists is central to therapeutic implementation. There is a major unmet need for improved treatments for CKD in people with T1D. Ongoing and future studies will help to establish whether proven therapies for CKD in T2D are also safe and efficacious in people with T1D. Coordinated, cross\u2010specialty approaches to awareness, detection, and intervention for CKD are also needed to improve kidney, cardiovascular, and survival outcomes in people with T1D.<\/jats:p>","DOI":"10.1111\/dom.70180","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:43:21Z","timestamp":1759812201000},"page":"16-26","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"first","affiliation":[{"name":"Providence Medical Research Center Providence Inland Northwest Health  Spokane Washington, DC USA"},{"name":"Nephrology Division, Kidney Research Institute University of Washington School of Medicine  Seattle Washington, DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-1598","authenticated-orcid":false,"given":"Linong","family":"Ji","sequence":"additional","affiliation":[{"name":"Peking University People's Hospital Peking University Diabetes Centre  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-5233","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, UZ Gasthuisberg Katholieke Universiteit Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rosen","sequence":"additional","affiliation":[{"name":"Breakthrough T1D  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"e_1_2_9_2_1","article-title":"Prevalence and severity of chronic kidney disease in a population with type 1 diabetes from a United States health system: a real\u2010world cohort study","volume":"47","author":"Tuttle KR","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042018819863226"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2455"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315598502"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci17-0047"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S011"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0723"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.17323"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-024-02070-y"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-03944-4"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.236"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070739"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111732"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70155-X"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.16"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae044"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013091002"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1618"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-06015-1"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.05.012"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11491116"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2014.272328"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005081"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00208.2003"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V10122569"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v3.i1.1"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00701.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01937-x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab927"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2839"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034986"},{"issue":"4","key":"e_1_2_9_34_1","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac331"},{"key":"e_1_2_9_36_1","unstructured":"US Food and Drug Administration.Wegovy (semaglutide) US PI.2024;https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s011lbl.pdfAccessed August 15 2024."},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515920"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30180-9"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02074-8"},{"key":"e_1_2_9_42_1","unstructured":"European Medicines Agency.Summary of product characteristics (kerendia).2023;https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kerendia-epar-product-information_en.pdfAccessed April 2 2025."},{"key":"e_1_2_9_43_1","unstructured":"US Food and Drug Administration.Kerendia (finerenone) US prescribing information.2022;https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215341s001lbl.pdfAccessed April 2 2025."},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab777"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23-1023"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31150-X"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108269"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616011"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00203-5"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci25-0028"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30154-8"},{"key":"e_1_2_9_55_1","unstructured":"US Food and Drug Administration. Jardiance (empagliflozin) US prescribing information.2023;https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/202293s030lbl.pdf. Accessed July 29 2025."},{"key":"e_1_2_9_56_1","unstructured":"US Food and Drug Administration.Farxiga (dapagliflozin) US prescribing information.2024;https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/202293s030lbl.pdfAccessed July 29 2025."},{"key":"e_1_2_9_57_1","unstructured":"US Food and Drug Administration.Invokana (canagliflozin) US prescribing information.2023;https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/204042s040lbl.pdfAccessed April 2 2025."},{"key":"e_1_2_9_58_1","unstructured":"US Food and Drug Administration.Inpefa (sotagliflozin) US prescribing information.2023;https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/216203s000lbl.pdfAccessed April 2 2025."},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1749"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1087"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14060"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1749"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0924"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204233"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00322-4"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07700621"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0129"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30280-1"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1584"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13546"},{"key":"e_1_2_9_71_1","unstructured":"ClinicalTrials.gov.Dapagliflzoin plus pioglitzone in T1DM.2025;https:\/\/clinicaltrials.gov\/study\/NCT03878459?term=NCT03878459&rank=1&tab=tableAccessed August 27 2025."},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110908"},{"key":"e_1_2_9_73_1","unstructured":"ClinicalTrials.gov.Sotagliflozin to slow kidney function decline in persons with type 1 diabetes and diabetic kidney disease (SUGARNSALT).2025;https:\/\/clinicaltrials.gov\/study\/NCT06217302Accessed April 2 2025."},{"key":"e_1_2_9_74_1","unstructured":"ClinicalTrials.gov.Prevention of chronic kidney disease (CKD) progression in Type 1 diabetes with long term use of sodium\u2010glucose\u2010cotransporter inhibitors avoiding kidney hypoxia (PLUTO).https:\/\/clinicaltrials.gov\/study\/NCT061472322025Accessed May 27 2025."},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00042"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-00996-0"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061782"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14376"},{"key":"e_1_2_9_79_1","unstructured":"ClinicalTrials.gov.Trial of semaglutide for diabetic kidney disease in type 1 diabetes (RT1D).2024;https:\/\/clinicaltrials.gov\/study\/NCT05822609Accessed April 2 2025."},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16606"},{"key":"e_1_2_9_81_1","unstructured":"ClinicalTrials.gov.Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes (Steno1).2025;https:\/\/clinicaltrials.gov\/study\/NCT06082063?term=NCT06082063&rank=1&tab=tableAccessed August 27 2025."},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000515"},{"key":"e_1_2_9_83_1","unstructured":"ClinicalTrials.gov.Acetazolamide in Persons With Type 1 Diabetes\u2014Crossover Trial.2025;https:\/\/clinicaltrials.gov\/study\/NCT06981234?term=NCT06981234&rank=1Accessed July 29 2025."},{"key":"e_1_2_9_84_1","unstructured":"ClinicalTrials.gov.Effect of montelukast on kidney and vascular function in type 1 diabetes.2024;https:\/\/clinicaltrials.gov\/study\/NCT05498116Accessed April 2 2025."},{"key":"e_1_2_9_85_1","unstructured":"ClinicalTrials.gov.A pilot study of fenofibrate to prevent kidney function loss in Type 1 diabetes (PERL\u2010FENO).2025;https:\/\/clinicaltrials.gov\/study\/NCT04929379Accessed May 27 2025."},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2024-004155"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.2337\/cd23-0063"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0119"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072144"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0027"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.70180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/full-xml\/10.1111\/dom.70180","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.70180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T16:58:08Z","timestamp":1772989088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.70180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/dom.70180"],"URL":"https:\/\/doi.org\/10.1111\/dom.70180","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"2025-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}